Search | IOVS | ARVO Journals

Showing 1 – 20 of 49

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Reduction of allergy symptoms in allergic rhinoconjunctivitis subjects treated with a low dose tacrolimus eye drop solution

Nicole Unger-Manhart; Svenja Sladek; Petra Zieglmayer; Patrick Lemell; Markus Savli; René Zieglmayer; Wolfgang Geitzenauer; Matthias Laengauer; Eva Prieschl-Grassauer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3562.

ARVO Annual Meeting Abstract April 2011

The Role of the Optical Coherence Tomography in Identifying Shape and Size of Idiopathic Epiretinal Membranes

Bilal Haj Najeeb; Michael Georgopoulos; Ramzi Sayegh; Wolfgang Geitzenauer; Ursula Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2194.

ARVO Annual Meeting Abstract April 2010

High-Resolution Optical Coherence Tomography Changes of the Neurosensory and Photoreceptor Layers Following Surgery for Vitreomacular Traction: Two-Year Follow-Up

C. G. Kiss; R. G. Sayegh; M. Georgopoulos; W. Geitzenauer; C. Simader; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2270.

ARVO Annual Meeting Abstract April 2010

Optical Coherence Tomography of Pigmented Choroidal Lesions Using 1060 nm Wavelength

W. Geitzenauer; M. Esmaeelpour; B. Hofer; M. Zehetmayer; W. Drexler; B. Povazay

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2283.

Retina May 2009

Evaluation of Ranibizumab-Induced Changes in High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual Function

PDF

Christopher G. Kiss; Wolfgang Geitzenauer; Christian Simader; Giovanni Gregori; Ursula Schmidt-Erfurth
TAGS: language morphology, morphology, optical coherence tomography, ranibizumab, vision
Invest. Ophthalmol. Vis. Sci.. 2009; 50(5):2376-2383. https://doi.org/10.1167/iovs.08-2017

ARVO Annual Meeting Abstract April 2009

Polarization-Sensitive Optical Coherence Tomography in Adult-Onset Foveomacular Vitelliform Dystrophy

F. Prager; E. Goetzinger; C. Ahlers; M. Pircher; B. Baumann; W. Geitzenauer; C. Schütze; C. Hitzenberger; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):762.

ARVO Annual Meeting Abstract April 2009

Evaluation of Microperimetric Findings in Normal Individuals: Shape and Size of Fixation Target

J. S. Kroisamer; C. Simader; W. Geitzenauer; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3277.

ARVO Annual Meeting Abstract April 2009

Spectral-Domain and Polarization-Sensitive Optical Coherence Tomography Findings in Pigmented Choroidal Lesions

W. Geitzenauer; E. Goetzinger; B. Baumann; M. Pircher; C. Schuetze; U. Schmidt-Erfurth; M. Zehetmayer; C. Hitzenberger

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3279.

ARVO Annual Meeting Abstract April 2009

Feasibility of Combined Spectral Domain Polarization Sensitive OCT and SLO for Clinical Retinal Imaging

B. Baumann; M. Pircher; E. Götzinger; H. Sattmann; C. Schütze; J. Lammer; W. Geitzenauer; C. Ahlers; U. Schmidt-Erfurth; C. K. Hitzenberger

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3778.

ARVO Annual Meeting Abstract April 2009

Evaluation of Central and Parafoveal Retinal Thickness Changes After Uneventful Cataract Surgery Using Two Spectral Domain Oct Devices

R. Dunavoelgyi; S. Sacu; G. Matt; W. Geitzenauer; W. Buehl; U. Schmidt-Erfurth; C. Pruente

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3793.

ARVO Annual Meeting Abstract April 2009

Degree of Polarization Uniformity - A New Intrinsic Tissue Specific Parameter for Characterizing RPE Disease by Polarization Sensitive OCT

C. K. Hitzenberger; B. Baumann; E. Götzinger; M. Pircher; C. Ahlers; C. Schuetze; W. Geitzenauer; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1385.

ARVO Annual Meeting Abstract April 2009

Evaluation of Ranibizumab-Induced Changes of High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual Function

C. G. Kiss; W. Geitzenauer; C. Simader; G. Gregori; M. Bolz; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1659.

ARVO Annual Meeting Abstract April 2009

Retinal Pigment Epithelium Changes in Clinically Normal Eyes

A. Grac; W. Geitzenauer; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5264.

ARVO Annual Meeting Abstract May 2008

Glaucoma Diagnosis Using Quantitative Analysis of Macular Raster Scanning HR-OCT

C. Vass; H. Resch; C. Hirn; W. Geitzenauer; C. Leydolt; B. Brela; C. Resch; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4653.

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab (Avastin®) Monotherapy versus Photodynamic Therapy Plus Intravitreal Triamcinolone for Neovascular Age-Related Macular Degeneration:12 Months Results of a Prospective, Randomized, Controlled Clinical Trial

F. Prager; S. Michels; S. Sacu; G. Weigert; R. Dunavölgyi; W. Geitzenauer; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1168.

ARVO Annual Meeting Abstract May 2008

Correlation of Fluorescence Angiography With Retinal- and Subretinal Fluid Pooling Identified in SD-OCT in Neovascular Age-Related Macular Degeneration

I. Golbaz; C. Ahlers; G. Stock; W. Geitzenauer; C. Pruente; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):916.

ARVO Annual Meeting Abstract May 2008

Three-Dimensional Analysis of Macular Edema Using Two Different Spectral Domain Oct Systems

R. G. Sayegh; C. Ahlers; I. Golbaz; P. Malamos; G. Stock; R. Dunavoelgyi; W. Geitzenauer; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):928.

ARVO Annual Meeting Abstract May 2008

Comparing Retinal Thickness Measurements From Cirrus Spectral-Domain and Stratus Time-Domain Optical Coherence Tomography

W. Geitzenauer; C. Kiss; M. Durbin; M. Wieland; N. Bressler; G. Gregori; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):930.

ARVO Annual Meeting Abstract May 2008

Retinal Pigment Epithelium Segmentation by Polarization Sensitive Optical Coherence Tomography

C. K. Hitzenberger; E. Götzinger; M. Pircher; W. Geitzenauer; C. Ahlers; B. Baumann; S. Michels; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1883.

ARVO Annual Meeting Abstract May 2008

Macular Function and Morphology in AREDS IV Patients During a 36-Month Observation Period

C. Wollinger; C. G. Kiss; C. Simader; W. Geitzenauer; S. Sacu; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2244.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Reduction of allergy symptoms in allergic rhinoconjunctivitis subjects treated with a low dose tacrolimus eye drop solution

The Role of the Optical Coherence Tomography in Identifying Shape and Size of Idiopathic Epiretinal Membranes

High-Resolution Optical Coherence Tomography Changes of the Neurosensory and Photoreceptor Layers Following Surgery for Vitreomacular Traction: Two-Year Follow-Up

Optical Coherence Tomography of Pigmented Choroidal Lesions Using 1060 nm Wavelength

Evaluation of Ranibizumab-Induced Changes in High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual Function

Polarization-Sensitive Optical Coherence Tomography in Adult-Onset Foveomacular Vitelliform Dystrophy

Evaluation of Microperimetric Findings in Normal Individuals: Shape and Size of Fixation Target

Spectral-Domain and Polarization-Sensitive Optical Coherence Tomography Findings in Pigmented Choroidal Lesions

Feasibility of Combined Spectral Domain Polarization Sensitive OCT and SLO for Clinical Retinal Imaging

Evaluation of Central and Parafoveal Retinal Thickness Changes After Uneventful Cataract Surgery Using Two Spectral Domain Oct Devices

Degree of Polarization Uniformity - A New Intrinsic Tissue Specific Parameter for Characterizing RPE Disease by Polarization Sensitive OCT

Evaluation of Ranibizumab-Induced Changes of High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual Function

Retinal Pigment Epithelium Changes in Clinically Normal Eyes

Glaucoma Diagnosis Using Quantitative Analysis of Macular Raster Scanning HR-OCT

Intravitreal Bevacizumab (Avastin®) Monotherapy versus Photodynamic Therapy Plus Intravitreal Triamcinolone for Neovascular Age-Related Macular Degeneration:12 Months Results of a Prospective, Randomized, Controlled Clinical Trial

Correlation of Fluorescence Angiography With Retinal- and Subretinal Fluid Pooling Identified in SD-OCT in Neovascular Age-Related Macular Degeneration

Three-Dimensional Analysis of Macular Edema Using Two Different Spectral Domain Oct Systems

Comparing Retinal Thickness Measurements From Cirrus Spectral-Domain and Stratus Time-Domain Optical Coherence Tomography

Retinal Pigment Epithelium Segmentation by Polarization Sensitive Optical Coherence Tomography

Macular Function and Morphology in AREDS IV Patients During a 36-Month Observation Period

To View More...

You must be signed into an individual account to use this feature.